Company Analysis Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
1. Summary
Advantages
- Price (18.08 HK$) is less than fair price (20.19 HK$)
- Dividends (5.96%) are higher than the sector average (5.7%).
- The company's current efficiency (ROE=12.11%) is higher than the sector average (ROE=5.19%)
Disadvantages
- The stock's return over the last year (-13.29%) is lower than the sector average (-4.78%).
- Current debt level 16.57% has increased over 5 years from 10.32%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 2.1% | 6.8% | 3.2% |
| 90 days | 0.1% | -10.5% | 21.8% |
| 1 year | -13.3% | -4.8% | 39.4% |
0874 vs Sector: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has significantly underperformed the "Healthcare" sector by -8.51% over the past year.
0874 vs Market: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has significantly underperformed the market by -52.7% over the past year.
Stable price: 0874 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 0874 with weekly volatility of -0.2555% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (18.08 HK$) is lower than the fair price (20.19 HK$).
Price not significantly lower than the fair price: The current price (18.08 HK$) is slightly lower than the fair price by 11.7%.
4.2. P/E
P/E vs Sector: The company's P/E (7.58) is lower than that of the sector as a whole (35.42).
P/E vs Market: The company's P/E (7.58) is lower than that of the market as a whole (26.7).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.8382) is lower than that of the sector as a whole (3.68).
P/BV vs Market: The company's P/BV (0.8382) is higher than that of the market as a whole (-11.94).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.4071) is lower than that of the sector as a whole (7.59).
P/S vs Market: The company's P/S indicator (0.4071) is lower than that of the market as a whole (2.76).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (7.92) is higher than that of the sector as a whole (2.91).
EV/Ebitda vs Market: The company's EV/Ebitda (7.92) is lower than that of the market as a whole (9.94).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 7.82% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (7.82%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (59.8%).
5.4. ROE
ROE vs Sector: The company's ROE (12.11%) is higher than that of the sector as a whole (5.19%).
ROE vs Market: The company's ROE (12.11%) is higher than that of the market as a whole (6.28%).
5.5. ROA
ROA vs Sector: The company's ROA (5.29%) is higher than that of the sector as a whole (3.47%).
ROA vs Market: The company's ROA (5.29%) is higher than that of the market as a whole (3.38%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 5.96% is higher than the average for the sector '5.7%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.96% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 5.96% has been growing over the last 5 years. Growth over 6 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (39.09%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
